Chlamydia and gonorrhea are soaring among young adults, many cases remain undetected. These infections can cause serious reproductive health problems or chronic pain, with chlamydia considered the most frequent cause of female infertility in developed countries. Our rapid CT/NG test delivers results within one patient visit to enable prompt and accurate treatment to prevent long term consequences and further spread.

LGV (Lymphogranuloma venereum) is a more invasive infection and is on the rise, especially among men who have sex with men and HIV positive persons. LGV requires a more rigorous treatment regimen than non-LGV but molecular testing to discriminate LGV from non-LGV infections is rarely done in current practice. Our test will be the first on the market that includes LGV detection to enable immediate individualized care and make additional testing and sample acquisition obsolete.

Influenza A/B, RSV and SARS CoV-2 infections have overlapping symptoms but affect each patient population differently. Our PCR accurate test can conveniently and affordably discriminate these respiratory viruses in less than 30 minutes for accurate patient management right from the beginning. Antiviral treatments for all four infections diseases are available, but each one is only effective against one of the viruses – the drugs are virus specific and only effective, if taken early during the infection. Rapid detection and discrimination is key to fast recovery.

UTIs are among the most common reasons to take antibiotics. Every year 150 million infections occur, about 95% are treated with antibiotics. More and more of these treatments fail because of drug resistance. Improper treatment is one of the main drivers of rising drug resistances. Diagnosis of UTI is often based on symptoms alone or unspecific parameters that do not discriminate potential causes. Our rapid, affordable and easy-to-use UTI test discriminates the causing pathogens and includes drug resistance markers to improve time to appropriate treatment, ensure faster symptom relief and minimize the improper or even unnecessary use of antibiotics.

Gonorrhea infections have become resistant to most antibiotics that could be successfully used for treatment in the past. Two antibiotic classes were lost to resistance since 2007 alone. Now, there is only one treatment option left that is globally recommended, and even for this drug occasional treatment failures have already been observed. As only very few new antibiotics are currently in development and their fate will likely be very similar, we must slow down the spread of resistance by smart use of the options that are still available. Many resistances can be detected by PCR, they are encoded in the pathogen’s genome. Our test can, in one run and in under 30 minutes, detect such genetic markers. This information can help to replace the last resort treatment option with an equally effective but no longer prescribed drug in around 70% of gonorrhea infections and therefore extend the lifetime of these critical drugs.
UTIs are the most common bacterial infection in women and are responsible for almost half of antibiotics prescriptions. Exact diagnosis is rarely done, but treatment has become more difficult due to drug resistance. Our test will lower the barrier to testing and enable resistance guided treatment of one of the most common infections.